Research Article
The Importance of Fever as a Predictive Symptom for the Potency of Host's Monocytes to Release Pro- and Anti-Inflammatory Mediators
Table 1
Demographic characteristics of 51 patients
with septic syndrome enrolled in the study.
| | Sepsis | Severe sepsis | Septic shock |
| Number | 38 | 10 | 3 | Male/Female | 15/23 | 3/7 | 0/3 | Age (mean ± SD) | | | | APACHE
II score (mean ± SD) | | | | White
blood cells
(/l, mean ± SD) | | | |
| Underlying infection [no. (%)] | | | | Lower
respiratory tract infection | 8
(21.1) | 4
(40.0) | 0 | Intrabdominal | 12 (31.6) | 2 (20.0) | 2 (66.7) | Acute pyelonephritis | 18 (47.4) | 4 (40.0) | 1 (33.3) |
| Bacteremia
[no. (% all
enrolled patients)] | | | | Providencia
stuartii | — | 2 (20.0) | — | Escherichia
coli | 4 (10.5) | — | — |
| Positive urine cultures
(>105 cfu/ml) [no. (%)] | | | | Escherichia
coli | 16 (42.1) | 3 (30.0) | 1 (33.3) | Pseudomonas
aeruginosa | 2 (5.3) | 1 (10.0) | — | Providencia
stuartii | — | 1 (10.0) | — |
| Administered antimicrobials [no. (%)] | | | | 2nd generation cephalosporin | 11 (28.9) | 1 (10.0) | — | 2nd generation cephalosporin + metronidazole | 10 (10.5) | 2 (20.0) | — | Ceftriaxone + macrolide | 8
(21.1) | 4
(40.0) | — | Piperacillin/tazobactam + vancomycin | 0 | 3 (30.0) | 3 (100) | Amplicilln/sulbactam | 9 (23.7) | — | — |
| Death (%) | 2 (5.3) | 1 (10.0) | 0 (0) |
|
|